Magnus Olafsson Corfitzen

Magnus Olafsson Corfitzen

Chief Executive Officer at ASCELIA PHARMA AB
51 year
Health Technology
Finance
Commercial Services

Profile

Magnus Olafsson Corfitzen is currently Chief Executive Officer at Ascelia Pharma AB since 2014.
Also holds director positions at Ascelia Incentive AB and Inventive AB. Former roles include Chief Executive Officer at CMC Contrast AB and Oncoral Pharma ApS, Chairman at FBC Device ApS, Investment Director at Danmarks Eksport- og Investeringsfond, Director at Vivostat A, Investment Director at Sunstone Capital A from 2007 to 2014, Director at DentoFit A, Nordic Vaccine A, Opsona Therapeutics Ltd., and Aro Medical ApS, Principal at McKinsey & Co., Inc., and Portfolio Manager at Danske Bank A and Danske Capital AB. Education includes graduation from the University of Aarhus in 1999.

Magnus Olafsson Corfitzen active positions

CompaniesPositionStart
ASCELIA PHARMA AB Chief Executive Officer 2013-12-31
Ascelia Incentive AB
Director/Board Member -
Inventive AB
Director/Board Member -

Former positions of Magnus Olafsson Corfitzen

CompaniesPositionEnd
Chief Executive Officer 2021-11-17
Director of Investments 2014-06-29
Director/Board Member 2014-01-26
Chief Executive Officer -
Corporate Officer/Principal -
See the detail of Magnus Olafsson Corfitzen's experience

Training of Magnus Olafsson Corfitzen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

17

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies17

Health Technology

Commercial Services

Finance

Finance

Finance

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Ascelia Incentive AB

Inventive AB

  1. Stock Market
  2. Insiders
  3. Magnus Olafsson Corfitzen